Perinatal HIV Research Unit of the University of the Witswatersrand
12
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
3 terminated/withdrawn out of 12 trials
50.0%
-36.5% vs industry average
17%
2 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial
Role: collaborator
HomeLink2: Reducing Posthospitalization Mortality Through Structured Home Care and Nutritional Support
Role: collaborator
Evaluating Smoking Cessation Interventions for PWH in South Africa
Role: collaborator
Kharituwe TB Contact Tracing Study
Role: collaborator
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa
Role: collaborator
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
Role: collaborator
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
Role: collaborator
Catalysing the Containment of COVID-19
Role: collaborator
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
Role: collaborator
Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa
Role: collaborator
A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa
Role: collaborator
Effectiveness of the Diaphragm for HIV Prevention
Role: collaborator
All 12 trials loaded